Unknown

Dataset Information

Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes.


ABSTRACT:

Purpose

Proteinuria is the second most common complication after hypertension after systemic administration of bevacizumab. Therefore we aimed to analyze the effect of intravitreal bevacizumab (IVB) injection on proteinuria in patients with diabetes.

Methods

Patients scheduled to receive IVB injection from May 1, 2018, to December 31, 2018, were prospectively enrolled. In total, 53 patients with diabetes (26 with nonproliferative diabetic retinopathy and 27 with proliferative diabetic retinopathy) and 37 patients without diabetes were included. Urine tests were performed within 1 month of and 7 ± 1 days after IVB injection. Urinary protein, creatinine, and albumin concentrations were quantitatively measured, and urinary protein-to-creatinine ratio and urinary albumin-to-crea

SUBMITTER: Chung YR 

PROVIDER: S-EPMC7396195 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature